{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:27:12Z","timestamp":1781245632703,"version":"3.54.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T00:00:00Z","timestamp":1418601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0115003","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T18:51:22Z","timestamp":1418669482000},"page":"e115003","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identifying and Validating a Combined mRNA and MicroRNA Signature in Response to Imatinib Treatment in a Chronic Myeloid Leukemia Cell Line"],"prefix":"10.1371","volume":"9","author":[{"given":"Steven","family":"Bhutra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Lenkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"LaCroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Stephanie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining","volume":"243","author":"JD Rowley","year":"1973","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"GQ Daley","year":"1990","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia","volume":"344","author":"BJ Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11912-001-0054-z","article-title":"STI571: a gene product-targeted therapy for leukemia","volume":"3","author":"MJ Mauro","year":"2001","journal-title":"Curr Oncol Rep"},{"key":"ref5","first-page":"114","article-title":"Chronic myelogenous leukemia: treatment and monitoring","volume":"107","author":"N Von Bubnoff","year":"2010","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0140-6736(95)92596-1","article-title":"UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council\u2019s Working Parties for Therapeutic Trials in Adult Leukaemia","volume":"345","author":"NC Allan","year":"1995","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2146\/ajhp070483","article-title":"New strategies in controlling drug resistance in chronic myeloid leukemia","volume":"64","author":"D Frame","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"ref8","unstructured":"Pollack A (25 April 2013) Cancer Physicians Attack High Drug Costs. The New York Times. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nytimes.com\/2013\/04\/26\/business\/cancer-physicians-attack-high-drug-costs.html?pagewanted=2&google_editors_picks=true&_r=1\" xlink:type=\"simple\">http:\/\/www.nytimes.com\/2013\/04\/26\/business\/cancer-physicians-attack-high-drug-costs.html?pagewanted=2&amp;google_editors_picks=true&amp;_r=1<\/ext-link>. Accessed 17 July 2014."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3892\/or.2012.2153","article-title":"Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib","volume":"29","author":"M Gromicho","year":"2013","journal-title":"Oncol Rep"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000336610","article-title":"Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia","volume":"127","author":"L Nardinelli","year":"2012","journal-title":"Acta Haematol"},{"key":"ref11","first-page":"1405","article-title":"[Effects of hOCT1 and ABCB1 gene on the efficacy of imatinib mesylate in chronic myelocytic leukemia]","volume":"92","author":"W Chen","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FPC.0b013e328360d10c","article-title":"ABCB1 single nucleotide polymorphisms (1236C&gt;T, 2677G&gt;T, and 3435C&gt;T) do not affect transport activity of human P-glycoprotein","volume":"23","author":"D Dickens","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/FPC.0b013e328350012b","article-title":"MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression","volume":"22","author":"E Turrini","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.leukres.2011.01.012","article-title":"Predictability of the response to tyrosine kinase inhibitors via in vitro analysis of Bcr-Abl phosphorylation","volume":"35","author":"M Shibata","year":"2011","journal-title":"Leuk Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1182\/blood-2010-08-304477","article-title":"Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression","volume":"117","author":"CM Lucas","year":"2011","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1751-553X.2011.01389.x","article-title":"Analysis of altered proteins related to blast crisis in chronic myeloid leukemia by proteomic study","volume":"34","author":"J Zhang","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.exphem.2012.05.010","article-title":"Phosphoprotein profiling predicts response to tyrosine kinase inhibitor therapy in chronic myeloid leukemia patients","volume":"40","author":"SE Jalkanen","year":"2012","journal-title":"Exp Hematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cancergen.2012.05.008","article-title":"KIT mutation detection in Tunisian patients with newly diagnosed myelogenous leukemia: prevalence and prognostic significance","volume":"205","author":"S Ouerhani","year":"2012","journal-title":"Cancer Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1182\/blood-2011-03-341073","article-title":"SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia","volume":"118","author":"N Esposito","year":"2011","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","article-title":"Expression of the miR-17\u201392 polycistron in chronic myeloid leukemia (CML) CD34+ cells","volume":"109","author":"L Venturini","year":"2007","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12185-012-1106-x","article-title":"Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia","volume":"96","author":"H Yang","year":"2012","journal-title":"Int J Hematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1158\/1535-7163.MCT-12-0550","article-title":"Suppression of survivin induced by a BCR-ABL\/JAK2\/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs","volume":"12","author":"S Stella","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/leu.2012.258","article-title":"C\/EBP\u03b2 promotes BCR\u2013ABL-mediated myeloid expansion and leukemic stem cell exhaustion","volume":"27","author":"Y Hayashi","year":"2012","journal-title":"Leukemia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/onc.2012.203","article-title":"Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias","volume":"32","author":"LA Tobin","year":"2013","journal-title":"Oncogene"},{"key":"ref25","article-title":"MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: The association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib","author":"Y-C Liu","year":"2013","journal-title":"Mol Carcinog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.exphem.2012.05.013","article-title":"Peroxisome proliferator-activated receptor activation increases imatinib uptake and killing of chronic myeloid leukemia cells","volume":"40","author":"L Wang","year":"2012","journal-title":"Exp Hematol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e35501","DOI":"10.1371\/journal.pone.0035501","article-title":"Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells","volume":"7","author":"O Hershkovitz Rokah","year":"2012","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1099\/mic.0.034793-0","article-title":"Integrating multiple \u201comics\u201d analysis for microbial biology: application and methodologies","volume":"156","author":"W Zhang","year":"2010","journal-title":"Microbiol Read Engl"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1128\/JB.186.20.6938-6943.2004","article-title":"Genomic Studies with Escherichia coli MelR Protein: Applications of Chromatin Immunoprecipitation and Microarrays","volume":"186","author":"DC Grainger","year":"2004","journal-title":"J Bacteriol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1128\/JB.187.17.6166-6174.2005","article-title":"Immobilization of Escherichia coli RNA Polymerase and Location of Binding Sites by Use of Chromatin Immunoprecipitation and Microarrays","volume":"187","author":"CD Herring","year":"2005","journal-title":"J Bacteriol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"T Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1752-0509-7-14","article-title":"Multilevel omic data integration in cancer cell lines: advanced annotation and emergent properties","volume":"7","author":"Y Liu","year":"2013","journal-title":"BMC Syst Biol"},{"key":"ref33","unstructured":"Auer H, Bakaletz A, Liu-Stratton Y, Sen C, Carter DE, <etal>et al<\/etal>. (2004) Imatinib effect on K562 leukemia cell line. GEO DataSets BioProjects: 34039\u201334944. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/bioproject\/PRJNA90947\" xlink:type=\"simple\">http:\/\/www.ncbi.nlm.nih.gov\/bioproject\/PRJNA90947<\/ext-link>. Accessed 15 June 2013."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"JP Radich","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/emboj.2012.25","article-title":"miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver","volume":"31","author":"K Okamoto","year":"2012","journal-title":"EMBO J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cas.12380","article-title":"MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells","volume":"105","author":"H Sakai","year":"2014","journal-title":"Cancer Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1158\/1535-7163.MCT-11-0592","article-title":"Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4","volume":"11","author":"K Ueno","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1477-7819-10-174","article-title":"MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features","volume":"10","author":"H Lee","year":"2012","journal-title":"World J Surg Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.18632\/oncotarget.1682","article-title":"microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers","volume":"5","author":"P Gasparini","year":"2014","journal-title":"Oncotarget"},{"key":"ref40","first-page":"600","article-title":"Imatinib mesylate in clinically suspected gastric stromal tumors","volume":"25","author":"Z-Y Li","year":"2013","journal-title":"Chin J Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1200\/JCO.2012.48.6365","article-title":"Phase II Trial of Imatinib in AIDS-Associated Kaposi\u2019s Sarcoma: AIDS Malignancy Consortium Protocol 042","volume":"32","author":"HB Koon","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.semarthrit.2012.06.001","article-title":"Therapeutic inhibition of tyrosine kinases in systemic sclerosis: a review of published experience on the first 108 patients treated with imatinib","volume":"42","author":"V-K Bournia","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s12011-013-9816-3","article-title":"Role of zinc in the regulation of autophagy during ethanol exposure in human hepatoma cells","volume":"156","author":"JP Liuzzi","year":"2013","journal-title":"Biol Trace Elem Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1158\/1078-0432.CCR-09-2006","article-title":"Three DNA methylation epigenotypes in human colorectal cancer","volume":"16","author":"K Yagi","year":"2010","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1101\/gr.6609207","article-title":"Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines","volume":"17","author":"K-P Kim","year":"2007","journal-title":"Genome Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2003-04-1150","article-title":"Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib","volume":"102","author":"K Wilkinson","year":"2003","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00384-009-0847-3","article-title":"Influence of NFkappaB inhibitors on IL-1beta-induced chemokine CXCL8 and \u221210 expression levels in intestinal epithelial cell lines: glucocorticoid ineffectiveness and paradoxical effect of PDTC","volume":"25","author":"Y Sunil","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jcp.23029","article-title":"Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients","volume":"227","author":"R Ciarcia","year":"2012","journal-title":"J Cell Physiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"D154","DOI":"10.1093\/nar\/gkm952","article-title":"miRBase: tools for microRNA genomics","volume":"36","author":"S Griffiths-Jones","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1371\/journal.pbio.0020363","article-title":"Human MicroRNA targets","volume":"2","author":"B John","year":"2004","journal-title":"PLoS Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0115003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:18:28Z","timestamp":1589037508000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0115003"}},"subtitle":[],"editor":[{"given":"Kristy L.","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,15]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0115003","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,15]]}}}